Boston-based venture capital firm Seae Ventures has launched a $107 million fund to invest in women and Black, Indigenous and other historically marginalized entrepreneurs who are developing health and financial technologies that benefit traditionally underrepresented populations. AHA is investing in the fund as part of its health equity investing strategy. 

“Hospitals and health systems have a vital role to play in building more equitable communities, but they can’t do it alone,” said AHA President and CEO Rick Pollack. “The American Hospital Association is excited to support partners like Seae Ventures that invest in health care technology companies and entrepreneurs who are too often left out of early financing. These investments will both tackle health inequity and create meaningful economic opportunity.” 

AHA also has invested in two other funds that finance historically marginalized entrepreneurs: Jumpstart Nova, which invests exclusively in Black-founded and -led startups focused on improving health care access and affordability; and SteelSky Ventures, a female-led venture capital firm focused on improving health outcomes for women.  
 

Related News Articles

Headline
The AHA today released its 2023 Environmental Scan, which provides key data and insights on the current health care landscape and can help organizations…
Headline
The Institute for Healthcare Improvement today launched Rise to Health: A National Coalition for Equity in Health Care, whose founding collaborators include…
Headline
The latest AHA podcast on leading initiatives to transform care and advance equity looks at Jefferson Health’s success in expanding diversity at the…
Perspective
As Congress convenes for its post-election lame-duck session, we are turning up the pressure to secure additional support for hospitals and the patients and…
Headline
AHA today urged the Drug Enforcement Administration to release its proposed rules outlining a special registration process for prescribing medically necessary…
Headline
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…